Phosphatases: Their Roles in Cancer and Their Chemical Modulators

Miriam Fontanillo1, Maja Köhn2

  • 1Genome Biology Unit, European Molecular Biology Laboratory, Meyerhofstrasse 1, 69117, Heidelberg, Germany.

Insights

Phosphatases, enzymes that remove phosphate groups, are crucial in cell processes. Contrary to past beliefs, they can act as both tumor suppressors and oncogenes in cancer, offering new therapeutic targets.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Phosphatases regulate cellular processes by dephosphorylating proteins, lipids, and signaling molecules.
  • Kinases, which phosphorylate cellular components, are key drug targets in cancer therapy.
  • Phosphatases counteract kinase activity, leading to their traditional classification as tumor suppressors.

Purpose of the Study:

  • To review the dual role of phosphatases in cancer.
  • To explore phosphatases as both tumor suppressors and oncogenes.
  • To discuss chemical modulators and therapeutic opportunities targeting phosphatases.

Main Methods:

  • Literature review and synthesis of current research findings.
  • Analysis of the roles of phosphatases in oncogenesis and tumor suppression.
  • Identification and discussion of chemical modulators and drug targets.

Main Results:

  • Phosphatases are not exclusively tumor suppressors; some function as oncogenes.
  • The role of phosphatases in cancer is complex and context-dependent.
  • Several phosphatases have been identified as potential oncogenes.

Conclusions:

  • The traditional view of phosphatases as solely tumor suppressors is outdated.
  • Phosphatases represent a promising class of targets for novel cancer therapies.
  • Targeting phosphatases requires a nuanced understanding of their oncogenic or tumor-suppressive functions.

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.5K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.6K
Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
55.4K
Phosphorylation01:02

Phosphorylation

7.9K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K